Professional Media briefs

Share this article:
Quadrant HealthCom is purchasing the journal publishing unit of Dowden Health Media from Lebhar-Friedman. The sale effectively moves Dowden's seven journals—including Mayo Clinic Proceedings and The Journal of Family Practice—into Quadrant's lineup.

Elsevier said it is re-launching Embase, its biomedical database of over 20 million indexed records from more than 7,000 active, peer-reviewed journals. Improvements include expanded usability and new retrieval tools, the company said.

Harvard, Johns Hopkins and eight other top medical schools received an inquiry from Sen. Charles Grassley (R-IA) about their ghostwriting policies. “Any attempt to manipulate the scientific literature…is very troubling,” Grassley wrote the schools, according to the New York Times.

Unbound Medicine released Evidence Central, an integrated, evidence-based tool for mobile devices and the web. Cochrane Abstracts and Evidence-Based Medicine Guidelines are designed to deliver answers to problem-based questions while graded and validated EE+ POEMs (Patient-Oriented Evidence that Matters from Essential Evidence Plus) and MEDLINE Journals are offered daily.
Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Is your marketing strategy stuck in 2005?

Is your marketing strategy stuck in 2005?

It is not enough to just have a killer black book or Rolodex. The market needs agile, swift marketing

Is guidance stifling social media?

Recent FDA draft guidance was meant to help companies create FDA-compliant tweets and handle third-party misinformation on the web. What other obstacles lie in the path of effective social media use?

FDA social media guides draw flak

FDA social media guides draw flak

Two FDA guidance documents on how health product manufacturers may participate in social media have drawn criticism from industry and consumer groups.